Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

*Product:*	Xofluza
Active Ingredient:	Baloxavir marboxil 20mg
Dosage Form:	Film coated tablet
New Zealand Sponsor:	Roche Products (NZ) Limited
Manufacturer:	Shionogi Pharma Co. Limited, Settsu, Japan

*Product:*	Xofluza
Active Ingredient:	Baloxavir marboxil 40mg
Dosage Form:	Film coated tablet
New Zealand Sponsor:	Roche Products (NZ) Limited
Manufacturer:	Shionogi Pharma Co. Limited, Settsu, Japan

Dated this 4th day of October 2021.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Schedule